Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation

J Cell Sci. 2013 Sep 1;126(Pt 17):3990-9. doi: 10.1242/jcs.129387. Epub 2013 Jun 26.

Abstract

The crucial role the Crumbs and Par polarity complexes play in tight junction integrity has long been established, however very few studies have investigated the role of the Scribble polarity module. Here, we use MCF10A cells, which fail to form tight junctions and express very little endogenous Crumbs3, to show that inducing expression of the polarity protein Scribble is sufficient to promote tight junction formation. We show this occurs through an epithelial-to-mesenchymal (EMT) pathway that involves Scribble suppressing ERK phosphorylation, leading to downregulation of the EMT inducer ZEB. Inhibition of ZEB relieves the repression on Crumbs3, resulting in increased expression of this crucial tight junction regulator. The combined effect of this Scribble-mediated pathway is the upregulation of a number of junctional proteins and the formation of functional tight junctions. These data suggests a novel role for Scribble in positively regulating tight junction assembly through transcriptional regulation of an EMT signaling program.

Keywords: EMT; ERK; Mammary epithelium; Polarity; Scribble; Tight junctions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes / pharmacology
  • Chromones / pharmacology
  • Down-Regulation
  • Epithelial-Mesenchymal Transition / physiology*
  • Flavonoids / pharmacology
  • HEK293 Cells
  • Homeodomain Proteins / antagonists & inhibitors
  • Homeodomain Proteins / biosynthesis
  • Homeodomain Proteins / metabolism*
  • Humans
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • MAP Kinase Kinase 1 / antagonists & inhibitors
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Membrane Glycoproteins / biosynthesis
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / metabolism*
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Morpholines / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • RNA Interference
  • RNA, Small Interfering
  • Tight Junctions / metabolism*
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / biosynthesis
  • Transcription Factors / metabolism*
  • Transcription, Genetic
  • Transcriptional Activation
  • Tumor Suppressor Proteins / biosynthesis
  • Tumor Suppressor Proteins / metabolism*
  • Zinc Finger E-box-Binding Homeobox 1

Substances

  • Anthracenes
  • CRB3 protein, human
  • Chromones
  • Flavonoids
  • Homeodomain Proteins
  • Membrane Glycoproteins
  • Membrane Proteins
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • SCRIB protein, human
  • Transcription Factors
  • Tumor Suppressor Proteins
  • ZEB1 protein, human
  • Zinc Finger E-box-Binding Homeobox 1
  • pyrazolanthrone
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • JNK Mitogen-Activated Protein Kinases
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • MAP Kinase Kinase 1
  • MAP2K1 protein, human
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one